ZTOX

Orchid Pharma Q4 FY26 Earnings Call Transcript Now Available on BSE

Orchid Pharma conducted its Q4 and FY2026 earnings call on May 26, 2026, covering performance for the quarter and financial year ending March 31, 2026.

Orchid Pharma Q4 & FY2026 Earnings Call Transcript Released on BSE

Orchid Pharma conducted its Q4 and FY2026 earnings call with analysts and investors on May 26, 2026, covering the quarter and financial year ended March 31, 2026.

Orchid Pharma Q4 FY2026 Earnings Call Transcript Now Available

Orchid Pharma published its Q4 and full-year FY2026 earnings call transcript on BSE following the May 26 analyst briefing covering quarter ended March 31.

Nureca Limited Issues Corrigendum to Board Meeting Outcome on BSE

Nureca Limited has submitted a corrigendum to its board meeting outcome originally filed on May 29, 2026, according to BSE filings. Details remain limited pending full disclosure.

Orchid Pharma Q4 FY26 Earnings Call Transcript Available on BSE

Orchid Pharma has filed its Q4 and full-year FY2026 earnings call transcript with BSE following the analyst meet held on May 26, 2026.

Orchid Pharma Q4 FY2026 Earnings Call Transcript Filed on BSE

Orchid Pharma has released the transcript of its Q4 and FY2026 earnings call with analysts and investors, held on May 26, 2026, as per BSE filing.

Orchid Pharma Q4 & FY26 Earnings Call Transcript Now Available

Orchid Pharma has released the transcript of its analyst and investor earnings call held on May 26, 2026 covering Q4 and the full financial year ended March 31, 2026.

Nureca (NURECA) Files Corrigendum with BSE on Board Meeting Outcome

Nureca Limited (NURECA) has filed a corrigendum with BSE regarding the board meeting outcome announced on May 29, 2026, prompting market attention on the correction.

Nureca Limited Files Corrigendum to Board Meeting Outcome on BSE

Nureca Limited has submitted a corrigendum to the Bombay Stock Exchange regarding the outcome of its board meeting originally filed on May 29, 2026.

Nureca Limited Files Corrigendum to Board Meeting Outcome with BSE

Nureca Limited (NURECA) has submitted a Corrigendum to BSE related to its Board Meeting outcome filed on May 29, 2026.

Nureca Limited Files Corrigendum for Board Meeting Outcome on BSE

Nureca Limited has notified BSE regarding a corrigendum to the Board Meeting outcome submitted on May 29, 2026. The corrigendum indicates a correction or clarification to the earlier filing.